Mary Caffrey is the Executive Editor for The American Journal of Managed Care® (AJMC®). She joined AJMC® in 2013 and is the primary staff editor for Evidence-Based Oncology, the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for AJMC®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for AJMC readers.
Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on LinkedIn.
Analysis Finds Steep Rise in Healthcare Cost-Sharing Over Past Decade
The rise in employee cost-sharing for healthcare predates Obamacare but has taken off since the law passed in 2010. Higher deductibles have been accompanied by stagnant wages, ensuring that the higher payments are deeply felt.
Tennessee Legislators Make Next Move to Deny Mental Health Care to LGBT Patients
The effort to allow counselors to deny mental health services comes a week after Mississippi Governor Phil Bryant signed a law to let counselors escape similar liability and let physicians deny transgender patients access to gender reassignment care.
Overcoming Stigma Essential to Improving Payer Coverage for Obesity
While payer coverage for obesity care has improved since the American Medical Association declared that obesity is a disease, there's still a long way to go. Physician training must improve to eliminate stigma that keeps patients from getting care they need, according to experts who appeared at Patient-Centered Diabetes Care.
Filling Gaps in Diabetes Care With the Retail Clinic
Growth in retail health clinics reveals unmet medical needs for Americans who lack insurance, who cannot leave work, or who have disconnected with the health system. This growing sector of the health system is diagnosing and treating diabetes cases that would otherwise be missed.
Lancet: Global Diabetes Population Reaches 422M; Most New Cases in Low- and Middle-Income Countries
While this study focused on calculating the global burden of diabetes, it comes as advocacy groups are stepping up calls for soda taxes marketing limits to rein in the effect of unhealthy food and drink on poor countries.
PCSK9 Inhibitor Cuts Cholesterol for the Statin Intolerant - but Price Not Worth It, JAMA Says
Results from the GAUSS-3 trial presented Sunday at the American College of Cardiology should be good news for Amgen, but an editorial in JAMA says the cost of evolocumab exceeds "willingness to pay" limits.
Surprise: Express Scripts Data Show Statin Use Fell After New Cholesterol Guideline
The 2013 guideline update from the American College of Cardiology and the American Heart Association drew criticism when it was presented. Data presented in today's poster session at the ACC Scientific Session revealed unexpected results.
Statins Can Cut Heart Attacks in Moderate-Risk Patients, Study Finds
Results from the HOPE-3 trial, presented on the opening day of the 65th Scientific Session of the American College of Cardiology, suggest cholesterol-lowering statins could have preventive benefits in broader groups of patients than previously thought.
Horizon, Newark's University Hospital Announce Value-Based Effort for Pregnancies
The value-based care initiative comes at a crucial time for the safety-net hospital: the vast majority of pregnancies are covered by Medicaid and some are covered by charity care. The latter funding source is being cut in the proposed New Jersey state budget.